Mesenchymal drift may explain how aging cells lose their identity
A new review argues that aging may not be just a collection of molecular defects, but a progressive drift in…
Author: Team Health Accessible
New T-cell engager therapy shows effectiveness in advanced solid tumors
A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University…
The right seafood choices can help diets meet health and climate goals
A new review shows fish can help bridge nutrition and sustainability goals, but only when consumers choose lower-impact species and…
Higher-dose ocrelizumab depletes more B cells but does not slow MS progression
A major analysis shows that more drug exposure does not always mean better disease control, as high-dose ocrelizumab cleared more…
Novel PRRT approach shows promise in advanced neuroendocrine tumors
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have…
Why new Alzheimer’s drugs are dividing regulators worldwide
New Alzheimer’s drugs are raising hopes, but modest benefits, ARIA safety risks, high costs, and regulatory disagreements show how uncertain…
New PET imaging approach may enable early CTE diagnosis
A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated…
Predictive model helps tailor PSMA therapy for prostate cancer patients
A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose…
High-risk prostate cancer patients benefit from perioperative apalutamide therapy
High-risk localized and locally advanced prostate cancer patients treated with apalutamide – a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)…
Daraxonrasib significantly extends survival in metastatic pancreatic cancer
At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing…